[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600969":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":18,"responsibleParty":36,"collaborators":40,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":51,"minAge":52,"maxAge":7,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Square2 Systems, Inc.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"OTHER","Cogito digital therapeutics development platform","Cogito will provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics for the prevention, treatment and\u002For management of any disease or disorder. This platform will allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide all the components for building a digital therapeutic for any health condition and population. Overall, Cogito offers great promise to markedly accelerate the pace and impact of science based digital therapeutics.",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":7},"Square2 Systems","CONTACT","(802) 526-4608",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Square 2 Systems","RECRUITING","Hanover","New Hampshire","03755","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-72.28954,43.70229,{"lat":31,"lon":30},[34],{"name":35,"role":16,"phone":17,"phoneExt":7,"email":7},"Research Coordinator",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Grabinski","Principal Investigator",[41],{"name":42,"class":43},"National Institute on Drug Abuse (NIDA)","NIH","100600969","cogito-a-turnkey-solution-for-rapidly-developing-evaluating-deploying-and-scaling-digital-therapeutics-100600969",false,"NCT07104396","Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics","Inclusion Criteria:\n\n* At least 18 years\n* PhD and\u002For MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.\n* Training or trained in substance use disorder (SUDs) research.\n* Must state a specific interest in digital therapeutics for SUDs.\n\nExclusion Criteria:\n\n* Those who do not meet inclusion criteria.",true,"ALL","18 Years",{"count":54,"type":55},20,"ESTIMATED","OBSERVATIONAL","This is a research study to evaluate the usability of the Cogito digital therapeutics development platform.\n\nThe Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population.\n\nAnd in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).",[59],"Substance Use Disorders (SUDs)",[61,62,63],"digital therapeutics","substance use disorders","development platform","2025-08-05",{"date":66,"type":67},"2025-08-11","ACTUAL",{"date":69,"type":67},"2025-07-02",{"date":71,"type":55},"2025-08-31",{"name":5,"class":6},1]